Evaluation of Stronger Neo-Minophagen

Acute hepatitis B virus (HBV) is one of the most common causes of fulminant hepatitis, especially in the endemic area. ... SNMC were used for total 15 days.

沒有這個頁面的資訊。

由 WC Huang 著作 · 2023 · 被引用 1 次 — Stronger Neo-Minophagen C (SNMC) has demonstrated benefits in patients with hepatitis. We aimed to determine its usefulness in post-TACE ...

由 J Chen 著作 · 2014 · 被引用 3 次 — Objective: To compare the efficacy and safety of Stronger Neo-Minophagen C (SNMC) in the treatment of chronic hepatitis B. Methods: We searched MEDLINE ...

由 H Kumada 著作 · 2002 · 被引用 259 次 — Long-term treatment of chronic hepatitis C with glycyrrhizin [stronger neo-minophagen C (SNMC)] for preventing liver cirrhosis and hepatocellular carcinoma.

由 K Reddyvari 著作 · 2015 · 被引用 1 次 — There is increasing evidence to indicate the therapeutic efficacy of SNMC in normalizing liver function tests (LFT) in patients with acute hepatitis. Objectives ...

由 L Zhang 著作 · 2000 · 被引用 20 次 — It induces acute and chronic liver disease ranging from chronic hepatitis to hepatocellular carcinoma. So far, interferon is the only one drug used for the ...

由 L Zhang 著作 · 2002 · 被引用 52 次 — Based on these results, SNMC is safe and efficacious in lowering or normalizing ALT levels in patients with chronic hepatitis B in China, and an induction dose ...